¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"dominant wave length"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dominant character
    ¿ì¼ºÇüÁú
  • dominant complement
    ¿ì¼ºº¸Ã¼
  • dominant eye
    ¿ì¼¼¾È
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ
  • dominant hemisphere
    ¿ì¼º´ë³ú¹Ý±¸
  • dominant inheritance
    ¿ì¼ºÀ¯Àü
  • dominant mutation
    ¿ì¼ºµ¹¿¬º¯ÀÌ
  • dominant receptor
    ¿ì¼º¼ö¿ëü
  • dominant trait
    ¿ì¼º¼ÒÁú
  • homozygous dominant
    µ¿Á¾Á¢Çտ켺-
  • incompletely dominant
    ºÒ¿ÏÀü¿ì¼º-
  • sex-linked dominant inheritance
    ¼º¿¬°ü¿ì¼ºÀ¯Àü
  • X-linked dominant inheritance
    X¿¬°ü¿ì¼ºÀ¯Àü
  • alpha wave
    ¾ËÆÄÆÄ
  • anacrotic wave
    »óÇà°¢À¶±â¸ÆÆÄ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dominant trait
    ¿ì¼º¼ÒÁú
  • homozygous dominant
    µ¿Á¾Á¢Çտ켺
  • sex-linked dominant inheritance
    ¼º¿¬°ü¿ì¼ºÀ¯Àü
  • length bias
    ±â°£Â÷À̹ÙÀ̾
  • crown-heel length
    ¸Ó¸®¹ß²ÞÄ¡±æÀÌ
  • crown-rump length
    ¸Ó¸®¾ûµ¢±æÀÌ
  • tension length curve
    Àå·Â±æÀ̰
  • tension length diagram curve
    Àå·Â±æÀ̵µÇ¥°î¼±
  • length tension diagram
    ±æÀÌÀå·Â±×¸²Ç¥
  • tension length diagram
    Àå·Â±æÀ̵µÇ¥
  • focal length
    ÃÊÁ¡°Å¸®, ÃÊÁ¡±æÀÌ
  • force velocity length relation
    Èû¼Óµµ±æÀ̰ü°è
  • length-height index
    (¢¡altitudinal index) ¸Ó¸®³ôÀ̱æÀÌÁö¼ö
  • length
    ±æÀÌ
  • stride length
    °ÉÀ½°Å¸®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • U wave
    UÆÄ
  • V wave
    V ÆÄ
  • alpha wave
    ¾ËÆÄÆÄ ³úÆÄ(Òà÷î)ÀÇ .
  • anacrotic wave
    »óÇà°¢À¶±â¸ÆÆÄ(¡­Øæ÷î).
  • arterial wave
    µ¿¸ÆÆÄ.
  • arterial wave
    µ¿¸ÆÆÄ.
  • heat wave
    ¿­ÆÄ(Ëç̬).
  • heat wave
    ¿­ÆÄ(æð÷î).
  • phrenic wave
    Ⱦ°Ý¸·ÆÄµ¿(üô̰د÷îÔÑ).
  • plane wave
    Æò¸éÆÄ(øÁØü÷î).
  • pulse wave
    ¸ÆÆÄ(Øæ÷î).
  • pulse wave velocity
    ¸ÆÆÄÀüÆÄ¼Óµµ(Øæ÷îï³÷îáÜöô).
  • pulsed wave Doppler echocardiography
    °£ÇæÆÄÇüµµÇ÷¯½ÉÃÊÀ½ÆÄ¼ú(°Ë»ç).
  • q wave
    QÆÄ
  • q wave,in myocardial infarction
    ½É±Ù°æ»öÀÇ (QÆÄ)(ãýÐÉÌÛßá¡­)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dominant complement
    ¿ì¼ºº¸Ã¼(¡­ÜÍô÷).
  • dominant cystoid macular dystrophy
    ¿ì¼º³¶Æ÷Ȳ¹ÝÀÌ¿µ¾ç(Áõ)
  • dominant dystrophic epidermolysis bullosa
    ¿ì¼º ÀÌ¿µ¾ç¼º ¼öÆ÷¼º Ç¥Çǹڸ®Áõ
  • dominant exudative vitreoretinopathy
    ¿ì¼º»ïÃâÀ¯¸®Ã¼¸Á¸·º¯Áõ
  • dominant eye
    ¿ì¼¼¾È
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ(¡­ë¶îîí­).
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ(éÐàõë¶îîí­).
  • dominant hemisphere
    Áö¹è ´ë³ú¹Ý±¸
  • dominant hemisphere
    ¿ì¼º´ë³ú¹Ý±¸(¡­ÓÞÒàÚâϹ).
  • dominant hemisphere
    ¿ì¼º´ë³ú¹Ý±¸(¡­ÓÞÒàÚãϹ).
  • dominant inheritance
    ¿ì¼ºÀ¯Àü(¡­ë¶îî).
  • dominant mutation
    ¿ì¼º[µ¹¿¬]º¯ÀÌ
  • dominant mutation
    ¿ì¼º(µ¹¿¬)º¯ÀÌ(¡­ÔÍæ×ܨì¶).
  • dominant receptor
    ¿ì¼º¼ö¿ëü.
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • peristaltic wave
    ¿¬µ¿ÆÄ
  • propagation of ultrasonic wave
    ÃÊÀ½ÆÄÀÇ ÀüÆÄ
  • pulsed wave Doppler echocardiography
    °£ÇæÆÄÇüµµÇ÷¯½ÉÃÊÀ½ÆÄ¼ú(°Ë»ç)
  • quarter wave Matching
    4ºÐÇÒÆÄÁ¶È­Ãþ
  • radio wave
    ¶óµð¿ÀÀüÆÄ, ¶óµð¿ÀÆÄ, ¹æ¼ÛÆÄ
  • shock wave
    Ãæ°ÝÆÄ
  • shock wave lithotripsy
    Ãæ°ÝÆÄ¼â¼®¼ú
  • sine wave
    ½ÎÀÎÆÄ
  • sound wave
    À½ÆÄ
  • ultrashort wave
    ÃÊ´ÜÆÄ
  • ultrasound wave
    ÃÊÀ½ÆÄ
  • wave
    ÆÄ, ÆÄµ¿
  • wave function
    ÆÄÇü±â´É
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
F wave Flutter wave; Á¶µ¿ÆÄ
S-T [segment] in electrocardiography, the portion of the segment between the end of the S wave and the b...
SW seriously wounded; short waves; sinewave; slow wave; soap and water; social worker; spike wave; spir...
SWS slow-wave sleep; spike-wave stupor; steroid-wasting syndrome; Sturge-Weber syndrome
CR Length Crown to Rump Length
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CADASIL Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leucoencephalopathy
DCR Dominant Control Region
DF Dominant follicles
DFIC Dominant frequency instability coefficient
DN Dominant negative
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • echo train length
    ¿¡ÄÚ ¿­ ±æÀÌ
  • focal length
    ÃÊÁ¡ °Å¸®
    Áý±¤ ·»Áî·ÎºÎÅÍ ÃÖ´ë ÃÊÁ¡ À§Ä¡±îÁöÀÇ °Å¸®.
  • length monitoring system
    ±æÀÌ °¨Áö°è
  • length of dental arch
    Ä¡¿­±Ã ±æÀÌ
  • length of tooth
    Ä¡¾ÆÀå
    Ä¡¾ÆÀÇ ±æÀÌ.
  • optimal length
    ÃÖÀû ±æÀÌ
  • span length
    ½ºÆÒ ±æÀÌ, ½ºÆÒÀÇ ±æÀÌ
    2°³ÀÇ ÁöÁö´ë »çÀÌ¿¡ ÀÖ´Â º¸ÀÇ ±æÀÌ.
  • spatial pulse length
    °ø°£ ÆÞ½º ±æÀÌ
  • tension-length curve
    Àå·Â ±æÀÌ °î¼±
  • tension-length diagram curve
    Àå·ÂÀåµµ °î¼±
  • working length
    ±Ù°üÀå
  • amplified audible sound wave
    ÁõÆøµÈ °¡Ã» À½ÆÄ
  • arterial wave
    µ¿¸Æ ÆÄ
  • atrial T wave
    ½É¹æ TÆÄ
  • beta wave
    º£Å¸ ÆÄ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
kidney, polycystic, autosomal dominant A genetic disorder with autosomal dominant inheritance characterised by multiple cysts in both kidneys and progressive deterioration of renal function. It is usually caused by a mutant gene at the pkd1 locus on the short arm of chromosome 16, though mutations elsewhere in the genome can also cause the disease. The age of onset of symptoms varies widely.
(12 Dec 1998)
active length-tension curve The relationship between active isometric tension and preload (rest length) for a contracting muscle.
(05 Mar 2000)
amplified fragment length polymorphism <technique> Invented by KeyGene, a Dutch biotech company based in Wageningen, Holland. The technique is now merchandised under licence agreement by Perkin Elmer.
Selected markers are amplified in a PCR, which makes amplified fragment length polymorphism an easy and fast tool for strain identification in agriculture, botany, microbiology and animal breeding.
Acronym: AFLP
(05 Feb 1998)
arch length The amount of space required for the permanent teeth as measured from the mesial aspect of the first molar on one side to the mesial aspect of the first molar on the opposite side, as measured through the contact points along an imaginary line of the dental arch.
(05 Mar 2000)
arch length deficiency The difference between the available circumference of the dental arch and that required to accommodate the succedaneous teeth in proper alignment.
(05 Mar 2000)
available arch length <dentistry> The amount of space available for the permanent teeth around the dental arch from the first permanent molar on the left to the first permanent molar on the right.
(05 Mar 2000)
back focal length <microscopy> As measured on the principal axis, from the second lens vertex to the back focal point of the lens. It is not the equivalent of the focal length.
(05 Aug 1998)
bellows length <microscopy> The distance from the eye point to the image plane in a photomicrographic apparatus.
(05 Aug 1998)
bond length This is the distance between the nuclei of two atoms which have formed bonds with each other.
(09 Oct 1997)
passive length-tension curve The relationship between passive tension and preload (rest length) for a muscle at rest.
(05 Mar 2000)
required arch length The sum of the mesiodistal widths of the permanent teeth from first permanent molar to first permanent molar.
(05 Mar 2000)
resting length The length at rest from which a muscle develops maximum isometric tension.
(05 Mar 2000)
restriction fragment length polymorphism <molecular biology, technique> A method that allows familial relationships to be established by comparing the characteristic polymorphic patterns that are obtained when certain regions of genomic DNA are amplified (typically by PCR) and cut with certain restriction enzymes.
The variation in the length of DNA fragments produced by a restriction endonuclease that cuts at a polymorphic locus. Such variations are generated by mutations that create or abolish recognition sites for these enzymes.
This is a key tool in DNA fingerprinting, reflecting the existence of different alleles in the individual. Restriction fragment length polymorphism mapping is also used in plant breeding to see if a key trait such as disease resistance is inherited.
In principle, an individual can be identified unambiquously by restriction fragment length polymorphism hence the use of restriction fragment length polymorphism in forensic analysis of blood, hair or semen).
Similarly, if a polymorphism can be identified close to the locus of a genetic defect, it provides a valuable marker for tracing the inheritance of the defect.
Synonym: DNA fingerprinting.
Acronym: RFLP
(12 Jan 1998)
restriction length polymorphism Fragment length polymorphism, the existence of allelic forms recognizable by the length of fragments that result when the nucleotide chain is treated by a specific restriction enzyme that cleaves wherever a particular sequence of nucleotides occurs. A mutation in this sequence changes cleaving and hence the number of fragments.
(05 Mar 2000)
greatest length Measurement from the cranial to caudal end of the embryo prior to folding.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • blast wave
    ÆøÇ³
  • brain wave
    ³úÆÄ;¿µ°¨;¹¦¾È
  • carrier wave
    ¹Ý¼ÛÆÄ
  • cold wave
    ÇÑÆÄ;ÄݵåÆÄ¸¶
  • compressional (compression) wave
    ¾ÐÃàÆÄ
  • delta wave
    (ÀÇ)(³úÆÄÀÇ)µ¨Å¸ÆÄ(±íÀº ¼ö¸é »óÅ ¶§ º¸ÀÓ)
  • earthquake sea wave
    ÇØÀÏ
  • electric wave
    ÀüÆÄ
  • finger wave
    ¼Õ°¡¶ó°¡ ¿þÀ̺ê(±â¸§ ¹Ù¸¥ ¸Ó¸®¸£ ¼Õ°¡¶ôÀ¸·Î ´­·¯ ¸¸µê)
  • gravitational wave
    Áß·ÂÆÄ
  • gravity wave
    (À¯Ã¼ÀÇ)Áß·ÂÆÄ;=GRAVITATIONAL WAVE
  • green wave
    (¼­Çο¡¼­)´ÜÀýµÈ µ¥°¡ ¾ø´Â ±äÆÄµµ
  • ground wave
    Áö»óÆÄ
  • guided wave
    À¯µµµÈ ÀüÆÄ
  • heat wave
    ¿­ÆÄ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á